Cargando…
Targeting HSP90 for cancer therapy
Heat-shock proteins (HSPs) are molecular chaperones that regulate protein folding to ensure correct conformation and translocation and to avoid protein aggregation. Heat-shock proteins are increased in many solid tumours and haematological malignancies. Many oncogenic proteins responsible for the tr...
Autores principales: | Mahalingam, D, Swords, R, Carew, J S, Nawrocki, S T, Bhalla, K, Giles, F J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696754/ https://www.ncbi.nlm.nih.gov/pubmed/19401686 http://dx.doi.org/10.1038/sj.bjc.6605066 |
Ejemplares similares
-
Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib
por: Swords, Ronan, et al.
Publicado: (2009) -
Targeting TNF-α for cancer therapy
por: Burton, Elizabeth R, et al.
Publicado: (2009) -
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
por: Michelakis, E D, et al.
Publicado: (2008) -
Mathematical models of targeted cancer therapy
por: Abbott, L H, et al.
Publicado: (2006) -
The chaperone system in cancer therapies: Hsp90
por: Basset, Charbel A., et al.
Publicado: (2023)